Skin squamous cell cancer: The time is right for greater involvement of the medical oncologist

Journal of Clinical Oncology

Volumn 25, Issue 15, 2007, Pages 1953-1954

  Pfister, David G ^a   Halpern, Allan C ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2A INTERFERON; CALCIPOTRIOL; DICLOFENAC; EPIDERMAL GROWTH FACTOR RECEPTOR; GEFITINIB; HYDROCORTISONE; IMIQUIMOD; ISOTRETINOIN; RETINOIC ACID; RETINOID; VALERIC ACID; VASCULOTROPIN RECEPTOR 2;

CANCER CHEMOTHERAPY; CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RISK; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; DRUG EFFICACY; EDITORIAL; FOLLOW UP; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MEDICAL PROFESSION; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; PROFESSIONAL STANDARD; PROGNOSIS; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; SKIN CANCER; SQUAMOUS CELL CARCINOMA; SUN EXPOSURE; NOTE; ONCOLOGY; PATHOLOGY; SKIN TUMOR;

CARCINOMA, SQUAMOUS CELL; HUMANS; MEDICAL ONCOLOGY; SKIN NEOPLASMS;

EID: 34249950960     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2006.08.8252     Document Type: Editorial

References (18)

1. National Comprehensive Cancer Network: Non-melanoma skin cancers: NCCN Clinical Practice Guidelines in Oncology. http://www.nccn.org/professionals/ physician_gls/default.asp
2. Miller DL, Weinstock MA: Nonmelanoma skin cancer in the United States: Incidence. J Am Acad Dermatol 30:774-778, 1994
3. Alam M, Ratner D: Cutaneous squamous-cell carcinoma. N Engl J Med 344:975-983, 2001
4. Marcil I, Stern RS: Risk of developing a subsequent nonmelanoma skin cancer in patients with a history of nonmelanoma skin cancer: A critical review of the literature and meta-analysis. Arch Dermatol 136:1524-1530, 2000
5. Hemminki K, Dong C: Subsequent cancers after in situ and invasive squamous cell cancer of the skin. Arch Dermatol 136:647-651, 2000
6. Otley CC, Statsko T, Tope WD, et al: Chemoprevention of nonmelanoma skin cancer with systemic retinoids: Practical dosing and management of adverse effects. Dermatol Surg 32:562-568, 2006
7. Chen K, Craig JC, Shumack S: Oral retinoids for the prevention of skin cancers in solid organ transplant recipients: A systematic review of randomized controlled trials. Br J Dermatol 152:518-523, 2005
8. Euvrard S, Kanitakis J, Claudy A: Skin cancers after organ transplantation. N Engl J Med 348:1681-1691, 2003
9. Weimar VM, Ceilley RI, Goeken JA: Aggressive biologic behavior of basal- and squamous-cell cancers in patients with chronic lymphocytic leukemia or chronic lymphocytic lymphoma. J Dermatol Surg Oncol 5:609-614, 1979
10. Brewster AM, Lee JJ, Clayman GL, et al: Randomized trial of adjuvant 13-cis-retinoic-acid and interferon alpha for patients with aggressive skin squamous cell carcinoma. J Clin Oncol 25:1974-1978, 2007
11. Peters WA III, Liu PY, Barrett RJ II, et al: Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol 18:1606-1613, 2000
12. Bernier J, Vermorken JB, Koch WM: Adjuvant therapy in patients with resected poor-risk head and neck cancer. J Clin Oncol 24:2629-2635, 2006
13. Shimuzu T, Izumi H, Oga A, et al: Epidermal growth factor receptor overexpression and genetic aberrations in metastatic cutaneous squamous-cell carcinoma of the skin. Dermatology 202:203-206, 2001
14. Maubec E, Duvillard P, Velasco V, et al: Immunohistochemical analysis of EGFR and HER-2 in patients with metastatic squamous cell carcinoma of the skin. Anticancer Res 25:1205-1210, 2005
15. Glisson BS, Kim ES, Kies MS, et al: Phase II study of gefitinib in patients with metastatic/recurrent squamous cell carcinoma of the skin. J Clin Oncol 24:18S, 2006 (abstr 5531)
16. Strieth S, Hartschuh W, Pilz L, et al: Angiogenic switch occurs late in squamous cell carcinomas of the skin. Br J Cancer 82:591-600, 2000
17. Li VW, Ball RA, Vasan N, et al: Antiangiogenic therapy for squamous cell carcinoma using combinatorial agents. J Clin Oncol 23:16S, 2005 (abstr 3032)
18. Park YW, Younes MN, Jasser SA, et al: AEE788, a dual tyrosine kinase receptor inhibitor, induces endothelial cell apoptosis in human cutaneous squamous cell carcinoma xenografts in nude mice. Clin Cancer Res 11:1963-1973, 2005